News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
178,057 Results
Type
Article (8204)
Company Profile (38)
Press Release (169815)
Multimedia
Podcasts (13)
Webinars (1)
Section
Business (55885)
Career Advice (168)
Deals (9978)
Drug Delivery (22)
Drug Development (13576)
Employer Resources (20)
FDA (4854)
Job Trends (4251)
News (84713)
Policy (6978)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (3)
2024 BioMidwest Digital (3)
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (4)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (3)
Academia (759)
Accelerated approval (6)
Adcomms (8)
Allergies (21)
Alliances (19026)
ALS (35)
Alzheimer's disease (583)
Antibody-drug conjugate (ADC) (53)
Approvals (4841)
Artificial intelligence (188)
Autoimmune disease (5)
Automation (10)
Bankruptcy (57)
Best Places to Work (3683)
BIOSECURE Act (2)
Biosimilars (11)
Biotechnology (26)
Bladder cancer (21)
Brain cancer (15)
Breast cancer (116)
Cancer (869)
Cardiovascular disease (50)
Career advice (150)
Career pathing (4)
CAR-T (48)
Cell therapy (131)
Cervical cancer (11)
Clinical research (10885)
Collaboration (468)
Compensation (26)
Complete response letters (2)
COVID-19 (796)
CRISPR (17)
C-suite (94)
Cystic fibrosis (30)
Data (550)
Decentralized trials (1)
Depression (9)
Diabetes (54)
Diagnostics (5986)
Digital health (13)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (58)
Drug pricing (11)
Drug shortages (4)
Duchenne muscular dystrophy (44)
Earnings (19041)
Editorial (5)
Employer branding (3)
Employer resources (18)
Events (20651)
Executive appointments (266)
FDA (5297)
Featured Employer (7)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (397)
Gene editing (36)
Generative AI (19)
Gene therapy (116)
GLP-1 (116)
Government (1199)
Grass and pollen (1)
Guidances (22)
Healthcare (5035)
Huntington's disease (7)
IgA nephropathy (11)
Immunology and inflammation (25)
Indications (7)
Infectious disease (852)
Inflammatory bowel disease (34)
Inflation Reduction Act (2)
Influenza (20)
Intellectual property (22)
Interviews (23)
IPO (3704)
IRA (3)
Job creations (707)
Job search strategy (133)
Kidney cancer (5)
Labor market (6)
Layoffs (82)
Leadership (2)
Legal (750)
Liver cancer (17)
Lung cancer (110)
Lymphoma (79)
Machine learning (4)
Management (7)
Manufacturing (127)
MASH (18)
Medical device (3995)
Medtech (3998)
Mergers & acquisitions (6513)
Metabolic disorders (131)
Multiple sclerosis (29)
NASH (8)
Neurodegenerative disease (36)
Neuropsychiatric disorders (2)
Neuroscience (757)
NextGen: Class of 2025 (1429)
Non-profit (1370)
Northern California (761)
Now hiring (3)
Obesity (61)
Opinion (57)
Ovarian cancer (27)
Pain (22)
Pancreatic cancer (23)
Parkinson's disease (49)
Partnered (10)
Patents (48)
Patient recruitment (26)
Peanut (12)
People (15472)
Pharmaceutical (4)
Phase I (3300)
Phase II (4644)
Phase III (4206)
Pipeline (418)
Policy (12)
Postmarket research (336)
Preclinical (1252)
Press Release (40)
Prostate cancer (46)
Psychedelics (5)
Radiopharmaceuticals (152)
Rare diseases (122)
Real estate (1569)
Recruiting (8)
Regulatory (5697)
Reports (16)
Research institute (883)
Resumes & cover letters (25)
Rett syndrome (1)
RNA editing (1)
RSV (3)
Schizophrenia (10)
Series A (68)
Series B (47)
Service/supplier (4)
Sickle cell disease (10)
Southern California (575)
Special edition (4)
Spinal muscular atrophy (34)
Sponsored (8)
Startups (1274)
Stomach cancer (6)
Supply chain (12)
Tariffs (6)
The Weekly (13)
United States (6737)
Vaccines (151)
Venture capitalists (13)
Weight loss (29)
Women's health (8)
Worklife (1)
Date
Today (52)
Last 7 days (211)
Last 30 days (812)
Last 365 days (10439)
2025 (3463)
2024 (10715)
2023 (12104)
2022 (17120)
2021 (17797)
2020 (16223)
2019 (12104)
2018 (9047)
2017 (8944)
2016 (8469)
2015 (9309)
2014 (6624)
2013 (5642)
2012 (6123)
2011 (6283)
2010 (5412)
Location
Africa (187)
Alabama (12)
Alaska (2)
Arizona (67)
Arkansas (6)
Asia (10527)
Australia (1846)
California (1673)
Canada (580)
China (144)
Colorado (85)
Connecticut (103)
Delaware (51)
Europe (25876)
Florida (257)
Georgia (53)
Idaho (19)
Illinois (182)
India (8)
Indiana (91)
Iowa (5)
Japan (51)
Kansas (24)
Kentucky (6)
Louisiana (2)
Maine (23)
Maryland (244)
Massachusetts (1165)
Michigan (98)
Minnesota (118)
Missouri (35)
Montana (8)
Nebraska (15)
Nevada (8)
New Hampshire (39)
New Jersey (405)
New Mexico (19)
New York (669)
North Carolina (340)
North Dakota (7)
Northern California (761)
Ohio (85)
Oklahoma (5)
Oregon (8)
Pennsylvania (316)
Puerto Rico (1)
Rhode Island (16)
South America (246)
South Carolina (5)
Southern California (575)
Tennessee (43)
Texas (278)
Utah (103)
Virginia (59)
Washington D.C. (10)
Washington State (146)
West Virginia (1)
Wisconsin (40)
178,057 Results for "accelerate diagnostics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2024 Financial Results
March 24, 2025
·
14 min read
Press Releases
Accelerate Diagnostics Submits WAVE System and Gram-Negative Positive Blood Culture Menu to the FDA for 510(k) Clearance
March 21, 2025
·
5 min read
Press Releases
Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results
January 13, 2025
·
8 min read
Business
Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial Results
Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial preliminary results for the first quarter ended March 31, 2024.
May 8, 2024
·
14 min read
FDA
Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ System
September 30, 2024
·
6 min read
Press Releases
The ADDF’s Diagnostics Accelerator Authors New Paper on Ocular Biomarker Landscape, Highlighting Ocular Tests as a Tool for Early Detection of Alzheimer’s Disease
March 13, 2025
·
6 min read
Deals
Quest Diagnostics Completes Acquisition of Select PathAI Diagnostics’ Lab Assets from PathAI, Accelerating Adoption of AI and Digital Pathology to Speed Cancer Diagnosis
Quest Diagnostics, a leader in diagnostic information services, announced that it has completed its previously announced acquisition of PathAI Diagnostics from PathAI, with the goal to accelerate the adoption of AI and digital pathology to improve the diagnosis of cancer and other diseases.
June 11, 2024
·
3 min read
Press Releases
Accelerate Diagnostics Reports Third Quarter 2024 Financial Results
November 8, 2024
·
17 min read
Business
Accelerate Diagnostics Scheduled Call to Review 2024 First Quarter Results.
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Wednesday, May 8, 2024, at 4:30 p.m. Eastern Time to review 2024 first quarter results.
May 2, 2024
·
1 min read
Business
Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results
Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the fourth quarter and year ended December 31, 2023.
March 28, 2024
·
19 min read
1 of 17,806
Next
